HSV-2 is very common. About 12% of Americans aged 14 to 49 have it, which translates to roughly 47 million people living with the infection in the United States alone. Globally, an estimated 520 million people aged 15 to 49 carry HSV-2, making it one of the most widespread sexually transmitted infections on the planet.
How Common HSV-2 Is by the Numbers
The most recent national survey data from the CDC puts HSV-2 prevalence at 11.9% among Americans aged 14 to 49. That means roughly 1 in 8 people in that age range are infected. And because prevalence climbs steadily with age, older adults carry it at much higher rates: 21.2% of people in their 40s test positive, compared to just 0.8% of teenagers and 7.6% of people in their 20s.
Even with those numbers, the overall trend has been declining. HSV-2 prevalence dropped nearly 6 percentage points between 1999 and 2016, falling from 18% to about 12%. That said, the virus isn’t disappearing. An estimated 647,000 new infections still occur in the U.S. every year, and that number is projected to stay above 600,000 annually for the next few decades.
Who Is Most Affected
HSV-2 doesn’t affect all groups equally. Women are nearly twice as likely to have it as men: 15.9% versus 8.2%. This gap is largely biological. The mucous membrane tissue of the vagina and vulva is more susceptible to infection during sexual contact than the skin of the penis, so transmission from male to female happens more easily than the reverse.
Racial disparities are even more striking. Among non-Hispanic Black Americans, prevalence reaches 34.6%, roughly one in three people. For non-Hispanic white Americans and Mexican Americans, the rate is much lower, around 8% to 9%. Non-Hispanic Asian Americans have the lowest measured prevalence at 3.8%. These differences are driven by complex social and structural factors, including patterns of sexual networks and access to healthcare, not by biological differences between racial groups.
Why Most People Don’t Know They Have It
One of the reasons HSV-2 stays so widespread is that the majority of people who carry it have no idea. About 60% of new HSV-2 infections cause no noticeable symptoms at all. Of the remaining 40% that do cause symptoms, roughly one in five present in atypical ways, meaning the sores or discomfort might be mild enough to mistake for something else entirely: an ingrown hair, a yeast infection, or general irritation.
This creates a situation where most transmission happens from people who genuinely don’t know they’re infected. The virus can shed from the skin even when no sores are visible, which is why it continues to spread so efficiently despite being a well-known infection.
Why It’s Not Part of Routine STI Testing
If HSV-2 is this common, you might wonder why it doesn’t show up on a standard STI panel. The CDC specifically recommends against routine herpes blood testing for people without symptoms, and the reasoning comes down to test accuracy. Current herpes blood tests have a significantly higher false positive rate than tests for infections like chlamydia or gonorrhea. For someone at low risk of infection, a positive result is more likely to be wrong than right.
Timing also matters. If you’ve been recently exposed, a blood test can come back negative because your body hasn’t produced enough antibodies yet. So the test can miss real infections and flag ones that don’t exist, which is a poor combination for a screening tool. Testing is generally reserved for people who have visible symptoms or a known exposure to an infected partner.
Putting the Numbers in Perspective
HSV-2 is far more common than most people assume, partly because the stigma around it is disproportionate to its medical impact. For comparison, nearly half of Americans in the same age group carry HSV-1, the closely related virus traditionally associated with cold sores (though HSV-1 increasingly causes genital infections too). Between the two types, herpes simplex viruses infect the majority of the adult population.
The practical reality for most people with HSV-2 is that outbreaks, if they happen at all, tend to become less frequent and less severe over time. The first year after infection typically involves the most activity, and many people go years between episodes or never have a recognized outbreak. Antiviral medications can reduce outbreak frequency and lower the risk of transmitting the virus to partners, making it a manageable condition for the vast majority of people who have it.